These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 17063500)
1. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500 [TBL] [Abstract][Full Text] [Related]
2. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis. Trivanović D; Petkovic M; Stimac D Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site]. Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913 [TBL] [Abstract][Full Text] [Related]
4. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Trivanovic D; Petkovic M; Stimac D Cancer; 2007 Jun; 109(12):2623-4; author reply 2624. PubMed ID: 17487858 [No Abstract] [Full Text] [Related]
5. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study. Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognosis for carcinoma of unknown origin in elderly patients. Lu HJ; Chen KW; Tzeng CH; Liu JH; Chiou TJ; Yen CC; Chao TC; Teng HW; Chen MH; Liu CY; Wang WS; Chang PM; Yang MH Oncology; 2012; 83(1):24-30. PubMed ID: 22722484 [TBL] [Abstract][Full Text] [Related]
7. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643 [TBL] [Abstract][Full Text] [Related]
8. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies. Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH. Egberts F; Pollex A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A Onkologie; 2008 Jul; 31(7):380-4. PubMed ID: 18596385 [TBL] [Abstract][Full Text] [Related]
10. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer. Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169 [TBL] [Abstract][Full Text] [Related]
11. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer. Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329 [TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537 [TBL] [Abstract][Full Text] [Related]
13. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123 [TBL] [Abstract][Full Text] [Related]
14. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206 [TBL] [Abstract][Full Text] [Related]
15. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592 [TBL] [Abstract][Full Text] [Related]
16. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812 [TBL] [Abstract][Full Text] [Related]
17. Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT. van de Wouw AJ; Jansen RL; Griffioen AW; Hillen HF Anticancer Res; 2004; 24(1):297-301. PubMed ID: 15015611 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of selected clinical prognostic factors in patients with non-granulomatous lymphomas]. Rolski J Pol Merkur Lekarski; 1997 May; 2(11):324-6. PubMed ID: 9377682 [TBL] [Abstract][Full Text] [Related]
20. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Cengiz O; Kocer B; Sürmeli S; Santicky MJ; Soran A Med Sci Monit; 2006 Jun; 12(6):CR240-7. PubMed ID: 16733481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]